1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Apixaban vs rivaroxaban in patients with atrial fibrillation at high or low bleeding risk : A population-based cohort study
2024) In Heart Rhythm(
- Contribution to journal › Article
-
Mark
Impact of direct oral anticoagulants on ROTEM® variables; a sample size-calculated experimental study
(
- Contribution to journal › Article
- 2023
-
Mark
Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
(
- Contribution to journal › Article
- 2020
-
Mark
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and rivaroxaban in atrial fibrillation
(
- Contribution to journal › Article